CLCF1 运动诱导的肌蛋白 协议用于研究RANKL/OPG骨保护机制在绝经后骨质疏松症
Houling Zhao1, Hongfei Li1, Yanbin Sun2
1Department of Trauma Center, Central Hospital Affiliated to Shandong First Medical University.
Journal of visualized experiments : JoVE
|November 24, 2025
概括
心肌类细胞因子1 (CLCF1),是一种运动诱导的分子,通过抑制骨质细胞和促进骨质细胞来保护骨. 本研究协议概述了研究CLCF1在骨代谢中的作用的方法,并开发了治疗骨疾病的新疗法.
科学领域:
- 骨生物学和新陈代谢
- 免疫学 免疫学 免疫学
- 运动生理学 运动生理学
背景情况:
- 心肌类细胞因子1 (CLCF1) 是一种运动诱导的分子,与肌肉骨的益处有关.
- 随着年龄的增长,CLCF1水平下降,这表明它在与年龄相关的骨质损失中发挥了作用.
- 免疫骨交叉对维持骨平衡至关重要.
研究的目的:
- 系统地研究CLCF1在运动介导的骨保护中的调节作用.
- 通过免疫骨交叉来阐明CLCF1在骨代谢中的作用机制.
- 为研究CLCF1对骨的影响提供标准化方案.
主要方法:
- 临床样本分析和分子表征技术.
- 功能性测试包括定量聚合酶链反应 (qPCR),西部涂抹和CRISPR/Cas9基因编辑.
- 共同培养系统评估CLCF1对核因子-κB合体 (RANKL) /骨质保护素 (OPG) 信号轴的受体激活器的影响.
主要成果:
- 通过STAT1介导的骨质细胞抑制和STAT3介导的骨质细胞促进,CLCF1表现出双重的骨保护作用.
- 这项研究可以评估CLCF1的表达及其与骨矿物质密度的相关性.
- 促进了针对CLCF1的运动模仿干预措施的机制性评估.
结论:
- CLCF1通过免疫骨交叉声调节骨代谢,在调节骨代谢方面发挥着重要作用.
- 基于CLCF1的干预措施为与年龄相关的骨疾病提供了一种新的治疗策略,通过同时促进骨形成和抑制再吸收.
- 该协议支持进一步研究细胞因子介导的骨调节和治疗开发.
相关概念视频
01:31Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
01:40Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K